Find News

Filter articles

Applied Filters

Showing 941 to 950 of 1033 results

Teva asks US Supreme Court to stay ruling in Copaxone case

US08-04-2014Legal developments

Teva has filed an application with the US Supreme Court to stay a ruling by the US Court of Appeals for the Federal Circuit that allowed generic drug makers to enter the market before the expiry of Teva’s patents covering its $4.3 billion-a-year multiple sclerosis drug Copaxone.

Sun Pharma to acquire rival Ranbaxy for $3.2bn

India07-04-2014Mergers & acquisitions

Mumbai-based Sun Pharmaceutical Industries is buying Indian rival Ranbaxy Laboratories in a merger worth $3.2 billion, the companies have confirmed.

Eli Lilly drafts in Prasco to market Evista generic


Generic drug maker Prasco Laboratories has agreed to market and distribute an authorised generic version of Eli Lilly’s Evista (raloxifene hydrochloride) in the US.

Actavis wins Lialda generic appeal

US02-04-2014Legal developments

The US Court of Appeals for the Federal Circuit has reversed a lower court decision that found Actavis’s generic version of Shire’s ulcerative colitis drug Lialda (mesalamine) infringes US patent 6,773,720.

Lilly beats back challenge to Alimta patent

US01-04-2014Legal developments

The US District Court for the Southern District of Indiana has upheld a patent covering Eli Lilly’s second biggest drug Alimta (pemetrexed disodium), after a challenge by Teva’s US pharmaceutical arm.

US Supreme Court agrees to hear Copaxone appeal

India, Israel, US01-04-2014Legal developments

The US Supreme Court has agreed to hear Teva’s appeal against a Federal Circuit decision that invalidated a patent covering its $4.3 billion-a-year Copaxone (glatiramer acetate) drug, allowing Sandoz, Mylan and Natco to produce generic versions.

Novartis launches Gleevec action against Dr. Reddy’s

US28-03-2014Legal developments

Novartis has sued generic drugmaker Dr. Reddy’s Laboratories for infringing a patent related to its chronic myelogenous leukaemia drug Gleevec/Glivec (imatinib mesylate).

Mylan fights off Teva’s Perforomist challenge

US25-03-2014Legal developments

The US District Court for the Northern District of West Virginia has upheld the validity of four patents covering Mylan’s Perforomist (formoterol fumarate) inhalation solution.

Cephalon sues to protect cancer drug Treanda

US19-03-2014Legal developments

Teva-owned subsidiary Cephalon has sued Sun Pharma, claiming the Mumbai-based firm infringed a patent protecting its Treanda (bendamustine hydrochloride) product.

Pfizer sues to block Viagra generic

US18-03-2014Legal developments

Pfizer has filed patent infringement suits against India-based Torrent Pharmaceuticals in an attempt to stop it selling a generic version of erectile dysfunction drug Viagra (sildenafil citrate).

Showing 941 to 950 of 1033 results